Statistics
Total Visits
| Views | |
|---|---|
| Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes | 93 |
Total Visits Per Month
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes | 4 | 0 | 5 | 2 | 2 | 6 | 0 |
File Visits
| Views | |
|---|---|
| jcm-10-00985.pdf | 128 |
Top country views
| Views | |
|---|---|
| United States | 51 |
| China | 7 |
| Hong Kong | 6 |
| Spain | 5 |
| Ireland | 4 |
| Singapore | 3 |
| Ukraine | 3 |
| Greece | 2 |
| Russia | 2 |
| Germany | 1 |
Top cities views
| Views | |
|---|---|
| San Ramon | 9 |
| Fairfield | 7 |
| Ashburn | 6 |
| Dublin | 4 |
| Hangzhou | 3 |
| Menlo Park | 3 |
| Montilla | 3 |
| Mountain View | 3 |
| Redwood City | 3 |
| Singapore | 3 |